These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8842847)

  • 1. The Southern California Kaiser-Permanente Chemical Dependency Recovery Program evaluation: results of a treatment outcome study in an HMO setting.
    Ershoff D; Radcliffe A; Gregory M
    J Addict Dis; 1996; 15(3):1-25. PubMed ID: 8842847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.
    Satre DD; Mertens JR; Areán PA; Weisner C
    Addiction; 2004 Oct; 99(10):1286-97. PubMed ID: 15369567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical dependency patients with cooccurring psychiatric diagnoses: service patterns and 1-year outcomes.
    Chi FW; Satre DD; Weisner C
    Alcohol Clin Exp Res; 2006 May; 30(5):851-9. PubMed ID: 16634854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SBIRT outcomes in Houston: final report on InSight, a hospital district-based program for patients at risk for alcohol or drug use problems.
    InSight Project Research Group
    Alcohol Clin Exp Res; 2009 Aug; 33(8):1374-81. PubMed ID: 19426184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employed men and women substance abusers: job troubles and treatment outcomes.
    Slaymaker VJ; Owen PL
    J Subst Abuse Treat; 2006 Dec; 31(4):347-54. PubMed ID: 17084788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction for drug abusing ex-offenders: outcome of the California prevention and education project MORE project.
    Bowser BP; Jenkins-Barnes T; Dillard-Smith C; Lockett G
    J Evid Based Soc Work; 2010 Jan; 7(1):15-29. PubMed ID: 20178022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.
    McNeese-Smith D; Nyamathi A; Longshore D; Wickman M; Robertson S; Obert J; McCann M; Wells K; Wenzel SL
    Am J Drug Alcohol Abuse; 2007; 33(3):439-46. PubMed ID: 17613971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a managed care approach to HIV infection: effectiveness of an interdisciplinary team.
    Lê CT; Winter TD; Boyd KJ; Ackerson L; Hurley LB
    Am J Manag Care; 1998 May; 4(5):647-57. PubMed ID: 10179919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment.
    Schroder R; Sellman D; Frampton C; Deering D
    Drug Alcohol Rev; 2009 Nov; 28(6):663-8. PubMed ID: 19930021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
    McKay JR; Lynch KG; Shepard DS; Pettinati HM
    Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and cost impact of integrating substance abuse treatment and primary care.
    Parthasarathy S; Mertens J; Moore C; Weisner C
    Med Care; 2003 Mar; 41(3):357-67. PubMed ID: 12618639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives of effective treatment for alcohol and drug disorders.
    Hoffmann NG; Miller NS
    Psychiatr Clin North Am; 1993 Mar; 16(1):127-40. PubMed ID: 8456039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inpatient and outpatient outcomes in Missouri's alcohol and drug treatment programs.
    Hartmann DJ; Sullivan WP; Wolk JL
    J Health Soc Policy; 1993; 5(2):67-76. PubMed ID: 10171763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six- and twelve-month abstinence rates in inpatient alcoholics treated with either faradic aversion or chemical aversion compared with matched inpatients from a treatment registry.
    Smith JW; Frawley PJ; Polissar NL
    J Addict Dis; 1997; 16(1):5-24. PubMed ID: 9046442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes.
    Humphreys K; Moos RH
    Alcohol Clin Exp Res; 2007 Jan; 31(1):64-8. PubMed ID: 17207103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Catamnestic study on the efficacy of an intensive outpatient treatment programme for alcohol-dependent patients: impact of participation in AA on the abstinence rates].
    Bottlender M; Soyka M
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):150-5. PubMed ID: 15747224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.